LIVONGO HEALTH, INC. (LVGO): Price and Financial Metrics
LVGO Stock Summary
- LVGO's went public 1.27 years ago, making it older than merely 0.69% of listed US stocks we're tracking.
- LVGO's price/sales ratio is 54.34; that's higher than the P/S ratio of 96.08% of US stocks.
- With a year-over-year growth in debt of 2,563.5%, Livongo Health Inc's debt growth rate surpasses 98.92% of about US stocks.
- Stocks that are quantitatively similar to LVGO, based on their financial statements, market capitalization, and price volatility, are TYL, NEWR, EVBG, CYBR, and PD.
- Visit LVGO's SEC page to see the company's official filings. To visit the company's web site, go to www2.livongo.com.
LVGO Stock Price Chart Interactive Chart >
LVGO Price/Volume Stats
|Current price||$139.77||52-week high||$151.05|
|Prev. close||$145.40||52-week low||$18.76|
|Day high||$145.91||Avg. volume||3,040,795|
|50-day MA||$136.55||Dividend yield||N/A|
|200-day MA||$77.04||Market Cap||14.20B|
LIVONGO HEALTH, INC. (LVGO) Company Bio
Livongo Health, Inc. develops and operates a consumer digital health platform that provides smart, cellular-connected devices, supplies, informed coaching, data science-enabled insights and facilitates access to medications across multiple chronic conditions. It focuses on diabetes, hypertension, weight management, diabetes prevention, and behavioral health. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008 and is headquartered in Mountain View, CA.
LVGO Latest News Stream
|Loading, please wait...|
LVGO Latest Social Stream
View Full LVGO Social Stream
Latest LVGO News From Around the Web
Below are the latest news stories about Livongo Health Inc that investors may wish to consider to help them evaluate LVGO as an investment opportunity.
Helpful research report of M-Health Application Market Astonishing Growth By 2026 | WellDoc, Inc., Sanofi, Jawbone, FitBit, Inc., Livongo Health, Ginger.io, Inc., Omron healthcare
The ‘M-Health Application Market’ study added by Reports web, exhibits a comprehensive analysis of the growth trends present in the global business scenario. The study further presents conclusive data referring to the commercialization aspects, industry size and profit estimation of
Amwell (AMWL) is an interesting telehealth company which shows impressive growth rates which approximate 100% as the result of Covid-19. Telehealth is very hot space yet unlike some industry leaders the pre-Covid-19 growth was not so impressive to me, certainly in combination with sizable losses. For this reason shares probably...
Livongo Health, Inc. (LVGO) Management Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)
Livongo Health, Inc. (LVGO) Morgan Stanley 18th Annual Global Healthcare Conference Transcript September 16, 2020 9:30 AM ET Executives Jason Gorevic - Chief Executive Officer, Teladoc Health, Inc. Mala Murthy - Chief Financial Officer, Teladoc Health, Inc. Glen Tullman - Executive Chairman and Founder Dr. Jenny Schneider - President Analysts...
Teladoc Health Inc’s (NYSE: TDOC ) pro-forma revenue growth and synergy targets appear achievable, according to Credit Suisse. The Teladoc Health Analyst: Jailendra Singh upgraded Teladoc Health from Neutral to Outperform with a price target lifted from $225 to $249. The Teladoc Health Takeaways: The company formed by the merger of Teladoc Health and Livongo Health Inc (NASDAQ: LVGO ) could generate annual revenue of around $5 billion, with annual EBITDA of about $1.1 billion in 2025, Singh said in the upgrade note. The analyst named seven factors that are driving the upgrade: The combination of Teladoc and Livongo creates a … Full story available on Benzinga.com
Here are the biggest calls on Wall Street on Tuesday
LVGO Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!